Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate polyglutamates in red and white blood cells and disease activity in rheumatoid arthritis
NL-OMON52447Unknown
- Sponsor
- Reade
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by Reade. Primary endpoints: Relationship between RBC and PBMC MTX-PGn accumulation and disease activity, Association between MTX-PGn variability and FPGS splicing alterations and 3 more. Status: unknown.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON52447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52447.